Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | 0 | 0 | |||||||
| Gross profit | 0 | 0 | 0 | |||||||
| Operating expense | 9.25%136.62K | -9.25%505.6K | 102.53%175.21K | -21.08%97.98K | -17.15%107.35K | -42.34%125.05K | -50.12%557.12K | -78.32%86.51K | -56.14%124.14K | -19.32%129.58K |
| Selling and administrative expenses | 33.62%58.22K | -17.00%225.22K | 486.00%102.26K | -36.63%32.56K | -28.18%52.75K | -66.24%43.57K | -66.70%271.34K | -94.91%17.45K | -76.64%51.38K | -4.15%73.45K |
| -Selling and marketing expense | ---- | -96.05%1.38K | 101.12%500 | --875 | --0 | --0 | -78.69%34.8K | -545.93%-44.84K | --0 | 52.41%11.2K |
| -General and administrative expense | 33.62%58.22K | -5.37%223.84K | 63.37%101.76K | -38.34%31.68K | -15.26%52.75K | -28.15%43.57K | -63.69%236.55K | -81.30%62.29K | -66.01%51.38K | -10.15%62.25K |
| Research and development costs | 133.09%34.96K | 0.00%75K | 100.00%30K | 0.00%15K | 0.00%15K | -50.00%15K | -16.88%75K | -25.86%15K | 50.00%15K | -50.00%15K |
| Other operating expenses | -34.66%43.44K | -2.56%205.38K | -20.54%42.96K | -12.71%50.42K | -3.71%39.6K | 14.98%66.48K | -0.53%210.77K | 51.62%54.06K | 8.84%57.76K | -23.82%41.13K |
| Operating profit | -9.25%-136.62K | 9.25%-505.6K | -102.53%-175.21K | 21.08%-97.98K | 17.15%-107.35K | 42.34%-125.05K | 51.60%-557.12K | 78.32%-86.51K | 58.96%-124.14K | 22.84%-129.58K |
| Net non-operating interest income (expenses) | 0 | 0 | 0 | |||||||
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
| Other net income (expenses) | -136.93%-54.34K | 119.13%73.84K | -58.94K | -1.51K | -12.85K | 147.14K | 89.78%-385.95K | |||
| Gain on sale of security | -1,797.94%-54.34K | 26.06%-28.79K | ---11.57K | ---1.51K | ---12.85K | ---2.86K | ---38.93K | ---- | ---- | ---- |
| Special income (charges) | ---- | 91.68%-29.18K | ---- | ---- | ---- | ---- | 90.73%-350.6K | 70.60%-350.6K | --0 | ---- |
| -Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | -67.25%376.59K | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---25.99K | ---- | ---- | ---- |
| -Less:Write off | ---- | --29.18K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
| Other non-operating income (expenses) | ---- | 3,583.96%131.81K | ---18.19K | ---- | ---- | --150K | -38.37%3.58K | ---- | ---- | ---- |
| Income before tax | -964.71%-190.96K | 54.22%-431.75K | 50.44%-234.15K | 19.86%-99.48K | 7.23%-120.2K | 110.18%22.08K | 80.87%-943.07K | 70.35%-472.46K | 95.64%-124.14K | -6.11%-129.58K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -964.71%-190.96K | 54.22%-431.75K | 50.44%-234.15K | 19.86%-99.48K | 7.23%-120.2K | 110.18%22.08K | 80.87%-943.07K | 70.35%-472.46K | 95.64%-124.14K | -6.11%-129.58K |
| Net income continuous operations | -964.71%-190.96K | 54.22%-431.75K | 50.44%-234.15K | 19.86%-99.48K | 7.23%-120.2K | 110.18%22.08K | 80.87%-943.07K | 70.35%-472.46K | 95.64%-124.14K | -6.11%-129.58K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -964.71%-190.96K | 54.22%-431.75K | 50.44%-234.15K | 19.86%-99.48K | 7.23%-120.2K | 110.18%22.08K | 80.87%-943.07K | 70.35%-472.46K | 95.64%-124.14K | -6.11%-129.58K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -964.71%-190.96K | 54.22%-431.75K | 50.44%-234.15K | 19.86%-99.48K | 7.23%-120.2K | 110.18%22.08K | 80.87%-943.07K | 70.35%-472.46K | 95.64%-124.14K | -6.11%-129.58K |
| Diluted earnings per share | 0 | 50.00%-0.01 | -0.007 | 85.28%-0.0015 | 0 | 0 | 85.71%-0.02 | 0 | 87.50%-0.01 | -166.38%-0.01 |
| Basic earnings per share | 0 | 50.00%-0.01 | -0.007 | 85.28%-0.0015 | 0 | 0 | 85.71%-0.02 | 0 | 87.50%-0.01 | -166.38%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.